HIKMA FARMACEUTICA FDA Approval ANDA 065342

ANDA 065342

HIKMA FARMACEUTICA

FDA Drug Application

Application #065342

Documents

Other Important Information from FDA2008-01-17

Application Sponsors

ANDA 065342HIKMA FARMACEUTICA

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001INJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 250MG BASE/VIAL0CEFTRIAXONECEFTRIAXONE SODIUM
002INJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 500MG BASE/VIAL0CEFTRIAXONECEFTRIAXONE SODIUM
003INJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 1GM BASE/VIAL0CEFTRIAXONECEFTRIAXONE SODIUM
004INJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 2GM BASE/VIAL0CEFTRIAXONECEFTRIAXONE SODIUM

FDA Submissions

ORIG1AP2008-01-10
LABELING; LabelingSUPPL4AP2009-11-20
LABELING; LabelingSUPPL7AP2010-07-06
LABELING; LabelingSUPPL9AP2011-08-04
LABELING; LabelingSUPPL12AP2014-08-29STANDARD
LABELING; LabelingSUPPL14AP2020-09-11STANDARD
LABELING; LabelingSUPPL15AP2020-09-11STANDARD
LABELING; LabelingSUPPL22AP2022-01-13STANDARD

Submissions Property Types

SUPPL4Null7
SUPPL7Null7
SUPPL12Null15
SUPPL14Null15
SUPPL15Null15
SUPPL22Null7

TE Codes

001PrescriptionAP
002PrescriptionAP
003PrescriptionAP
004PrescriptionAP

CDER Filings

HIKMA FARMACEUTICA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65342
            [companyName] => HIKMA FARMACEUTICA
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFTRIAXONE","activeIngredients":"CEFTRIAXONE SODIUM","strength":"EQ 250MG BASE\/VIAL","dosageForm":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CEFTRIAXONE","activeIngredients":"CEFTRIAXONE SODIUM","strength":"EQ 500MG BASE\/VIAL","dosageForm":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CEFTRIAXONE","activeIngredients":"CEFTRIAXONE SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CEFTRIAXONE","activeIngredients":"CEFTRIAXONE SODIUM","strength":"EQ 2GM BASE\/VIAL","dosageForm":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CEFTRIAXONE","submission":"CEFTRIAXONE SODIUM","actionType":"EQ 250MG BASE\/VIAL","submissionClassification":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CEFTRIAXONE","submission":"CEFTRIAXONE SODIUM","actionType":"EQ 500MG BASE\/VIAL","submissionClassification":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CEFTRIAXONE","submission":"CEFTRIAXONE SODIUM","actionType":"EQ 1GM BASE\/VIAL","submissionClassification":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CEFTRIAXONE","submission":"CEFTRIAXONE SODIUM","actionType":"EQ 2GM BASE\/VIAL","submissionClassification":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.